Centre Hospitalier De Butare
Butare, Rwanda
NCT Number: NCT00329134
No pediatric formulations of quinine exist. Therefore, quinine tablets are broken into 2 or 4 parts, according to the body weight. Based on the body weight, 1/2 or 1/4 a tablet is administered to the child.
At this moment, quinine sulphate pellets are developed. These pellets enable an adequate dosing according to the body weight.
56 children with malaria will be dosed every 8 hours during 7 days with 10-15mg/kg body weight.
Looking for future studies?
Notify Me6 month–59 month
All sexes
Interventional
Phase 2
Butare, Rwanda
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Looking for future studies?
Notify MeUniversity Ghent
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01555255
Anemia, Birth Weight
Bobo-Dioulasso, Burkina Faso
View Trial DetailsNCT05050825
Acute Febrile Illness, Arbovirus Infections
Fatick, Senegal
View Trial DetailsNCT05889052
Anemia, Hematologic Diseases
Soa and Mbankomo, Cameroon
View Trial DetailsNCT05856357
Anemia, Hematologic Diseases
Séguéla, Côte d’Ivoire
View Trial Details